Back

Discovery and characterization of a long-acting relaxin analog, LY3540378, for the treatment of chronic heart failure

22 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Basic Science Drugs, Drug Targets HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Xiaojun Wang

Indianapolis (United States of America)

23 More presentations in this session

Presentation thumbnail
Characterization of right ventricular alterations induced by long-term intense exercise training in a rat model of athletes heart
Doctor A. Olah (Budapest, HU)
Abstract Slides
Presentation thumbnail
Psychomotor performance is relevant determinant of cardiopulmonary capacity
Doctor R. Skalik (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Comparison of systemic inflammation activity and patients immune status in patients with different forms of atrial fibrillation and flutter and heart failure
Doctor O. Marchenko (Kyiv, UA)
Abstract Slides
Presentation thumbnail
Inflammation markers as predictors of mortality in hospitalized patients infected with the SARS-COV-2
Mr J. Aguilar-Meza (Mexico City, MX)
Abstract Slides
Presentation thumbnail
Cardiac fibroblasts as central players in sex- and age-related differences in cardiac fibrosis and inflammation
Doctor K. Pappritz (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Basic Science

The Event

Event poster

Heart Failure 2022

22 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources